2016-2020 Emerging Opportunities in the German Hepatitis Diagnostic Testing Market
![](/report_cover/2215/2016-2020-emerging-opportunities-in-german-hepatitis-diagnostic-testing-market_en.gif)
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 241 pages and 14 tables
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 241 pages and 14 tables
I. INTRODUCTION
II. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
Classification
Transmission of Infection
Occupational Hazards
Acute Hepatitis
Diagnosis of Acute Infection
Chronic Hepatitis
HCV and Other Chronic Liver Diseases
Alcoholic Liver Disease
Hepatitis B Coinfection
Cirrhosis and Hepatocellular Carcinoma
Diagnostic Tests
Possible Indications for HCV RNA Testing
Conclusions and Future Direction
E. Hepatitis D
Historical Perspective
Epidemiology
HBV-HDV 'Coinfection' vs. 'Superinfection'
Methods of Detecting HDV
Prevention
F. Hepatitis E
Background
Prevalence of the Disease
Diagnostic Tests
Epidemiologic Serosurveys
Serologic Cross-Reactivity
G. Hepatitis G
Vaccines and Drugs
H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
II. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
Classification
Transmission of Infection
Occupational Hazards
Acute Hepatitis
Diagnosis of Acute Infection
Chronic Hepatitis
HCV and Other Chronic Liver Diseases
Alcoholic Liver Disease
Hepatitis B Coinfection
Cirrhosis and Hepatocellular Carcinoma
Diagnostic Tests
Possible Indications for HCV RNA Testing
Conclusions and Future Direction
E. Hepatitis D
Historical Perspective
Epidemiology
HBV-HDV 'Coinfection' vs. 'Superinfection'
Methods of Detecting HDV
Prevention
F. Hepatitis E
Background
Prevalence of the Disease
Diagnostic Tests
Epidemiologic Serosurveys
Serologic Cross-Reactivity
G. Hepatitis G
Vaccines and Drugs
H. Review of Leading Analyzers Marketed by: Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing Hepatitis Tests
Germany HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBs Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Hepatitis Delta Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBc Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBe Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Germany ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Hepatitis Testing Market Diagnostics Sales By Major Supplier
Germany Hepatitis C Testing Market Diagnostics Sales By Major Supplier
Major Companies Developing or Marketing Hepatitis Tests
Germany HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBs Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Hepatitis Delta Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBc Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Germany HBe Ag Test Volume and Diagnostics Sales Forecast By Market Segment
Germany ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment
Germany Hepatitis Testing Market Diagnostics Sales By Major Supplier
Germany Hepatitis C Testing Market Diagnostics Sales By Major Supplier